← All decks

Cardiology

Ethanol Septal Ablation

Built from Cardiovascular Catheterization and Intervention: A Textbook of Coronary, Peripheral, and Structural Heart Disease

What’s inside

9 sections · 101 slides

  1. 01

    Overview

    • Scope of this presentation

    1 slide

  2. 02

    Hypertrophic cardiomyopathy and outflow obstruction

    • Definition of hypertrophic cardiomyopathy
    • Diagnostic criteria
    • Clinical presentation
    • Pathophysiology of heart failure symptoms
    • Definition of left ventricular outflow tract obstruction
    • Mechanism of dynamic outflow obstruction
    • Mitral apparatus contributors to obstruction
    • Place of septal reduction therapy in management
    • Reverse remodeling after relief of obstruction
    • Sequence generating the dynamic outflow gradient

    10 slides

  3. 03

    History and evolution of the procedure

    • Origin of the technique
    • Haemodynamic proof of concept
    • The first three ablations
    • Findings and limitations of the first series
    • Knight 1997: early complication data
    • Lessons from the early two-centre series
    • Faber 1998: the 66-patient German cohort
    • Evolution of the procedure
    • Long-term outcomes in early registries
    • Meta-analysis of the early experience
    • Reported procedural complications
    • Technical refinements over three decades
    • Reduction in ethanol volume and formal training

    13 slides

  4. 04

    Contemporary outcomes and real-world experience

    • Guideline recommendation
    • Evidence base for the comparison with myectomy
    • Findings of the 2019 comparative meta-analysis
    • Indications favouring surgical myectomy
    • Typical profile of the ablation patient
    • Ablation at high-volume centres compared with myectomy
    • Effect of operator and institutional volume
    • Guideline benchmarks for high-volume centres
    • Real-world volume gap in the United States
    • Training requirements for new operators

    10 slides

  5. 05

    Patient selection

    • Mechanism of gradient relief after ethanol injection
    • Mechanism of sustained benefit after ablation
    • Indications for ethanol septal ablation
    • Absence of another surgical indication
    • Relative contraindications: patient factors
    • Relative contraindications: anatomical factors
    • Age and sex in the choice of therapy
    • Cardiac myosin inhibitors as an alternative
    • VALOR-HCM and deferral of septal reduction therapy
    • Candidates for myosin inhibitors rather than ablation
    • Limitations of myosin inhibitor therapy
    • Decision pathway for septal reduction therapy

    12 slides

  6. 06

    Preprocedure evaluation

    • Transthoracic echocardiography as the first step
    • What echocardiography must exclude
    • Accuracy of echocardiographic measurement
    • Right heart catheterisation in the workup
    • Invasive measurement of the outflow gradient
    • Simultaneous left ventricular and aortic pressure tracings
    • Pitfalls in invasive gradient measurement
    • Provocation and sedation during the study
    • Coronary angiography for target selection
    • Angiographic projections used before septal ablation
    • Angiographic projections and what each shows
    • Components of the preprocedure assessment

    12 slides

  7. 07

    Technique

    • Temporary transvenous pacemaker before ablation
    • Position of the pacing lead
    • Guide catheter selection and stability
    • Vascular access and anticoagulation
    • Wiring the septal perforator
    • Steps of alcohol septal ablation on angiography
    • Positioning the over-the-wire balloon
    • Septal artery calibre and balloon anchoring
    • Confirming occlusion before ethanol
    • Selective angiography through the balloon lumen
    • Selective injection with simultaneous contrast echocardiography
    • Myocardial contrast echocardiography during selection
    • Ethanol injection technique
    • The five-minute dwell
    • Doppler assessment during ablation
    • Outflow tract Doppler before and after ablation
    • Analgesia during ethanol injection
    • Monitoring during and after the injection
    • The final angiogram
    • Procedural sequence in summary

    20 slides

  8. 08

    Postprocedure care and procedural success

    • Immediate postprocedure care
    • Cardiac enzyme monitoring
    • Conduction surveillance after ablation
    • Immediate procedural success
    • Reassessment at three to six months
    • Centre of excellence targets for procedural success
    • Conclusion
    • Key points to carry away

    8 slides

  9. 09

    References

    • References
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • Cardiovascular Catheterization and Intervention: A Textbook of Coronary, Peripheral, and Structural Heart Disease
    • Join our WhatsApp groups

    7 slides